CA1289885C - Tissue growth regulation - Google Patents

Tissue growth regulation

Info

Publication number
CA1289885C
CA1289885C CA000520028A CA520028A CA1289885C CA 1289885 C CA1289885 C CA 1289885C CA 000520028 A CA000520028 A CA 000520028A CA 520028 A CA520028 A CA 520028A CA 1289885 C CA1289885 C CA 1289885C
Authority
CA
Canada
Prior art keywords
solution
temperature
biotin
acetyl
tissue growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000520028A
Other languages
English (en)
French (fr)
Inventor
Neil G.C. Hendry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of CA1289885C publication Critical patent/CA1289885C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000520028A 1985-10-08 1986-10-07 Tissue growth regulation Expired - Lifetime CA1289885C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8524807 1985-10-08
GB858524807A GB8524807D0 (en) 1985-10-08 1985-10-08 Tissue growth regulation

Publications (1)

Publication Number Publication Date
CA1289885C true CA1289885C (en) 1991-10-01

Family

ID=10586368

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000520028A Expired - Lifetime CA1289885C (en) 1985-10-08 1986-10-07 Tissue growth regulation

Country Status (10)

Country Link
EP (1) EP0239607A1 (cs)
JP (1) JPS63501077A (cs)
AU (1) AU606038B2 (cs)
CA (1) CA1289885C (cs)
CS (1) CS265224B2 (cs)
DD (1) DD272034A5 (cs)
GB (1) GB8524807D0 (cs)
IN (1) IN168295B (cs)
WO (1) WO1987002244A1 (cs)
ZA (1) ZA867664B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273900A (en) * 1987-04-28 1993-12-28 The Regents Of The University Of California Method and apparatus for preparing composite skin replacement
CA1318592C (en) * 1988-11-18 1993-06-01 University Of British Columbia N-acetyl glucosamine as a cytoprotective agent
US5192750A (en) * 1992-01-28 1993-03-09 The University Of British Columbia Method and composition for treatment of food allergy
US5217962A (en) * 1992-01-28 1993-06-08 Burton Albert F Method and composition for treating psoriasis
US5229374A (en) * 1992-01-28 1993-07-20 Burton Albert F Method for treatment of lower gastrointestinal tract disorders
US6046179A (en) * 1998-04-17 2000-04-04 Murch; Simon Composition for and treatment of inflammatory bowel disease by colon administration of N-acetylglucosamine
US6159485A (en) 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
CN1173706C (zh) 2001-02-28 2004-11-03 中国人民解放军第三军医大学 N-乙酰-d-氨基葡萄糖在制备治疗宫颈糜烂药物中的应用
CN1199645C (zh) 2002-08-13 2005-05-04 中国人民解放军第三军医大学 N－乙酰－d－氨基葡萄糖在制备治疗泌尿生殖道感染药物中的应用
US20070207198A1 (en) * 2003-09-17 2007-09-06 Beijing Sino-Hong Kong Dafu Science & Technology Of Biowave Co., Ltd. Use Of N-Acety1-D-Glucosamine In The Manufacture Of Medicaments For Anti-Tumors And Anti-Metastasis
WO2005112948A1 (ja) * 2004-05-21 2005-12-01 Tottori University 創傷の治療又は処置のための薬剤
ITBS20070178A1 (it) * 2007-11-15 2009-05-16 Paoli Ambrosi Gianfranco De Composizione per uso farmaceutico e/o cosmetico e/o in forma di dispositivo medico per favorire processi di cicatrizzazione, per il trattamento di cicatrici ipertrofiche e per migliorare le proprieta' biomeccaniche della cute

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3232836A (en) * 1959-08-24 1966-02-01 Pfizer & Co C Facilitating healing of body surface wounds by intravenous administration of n-acetyl glucosamine, glucosamine, or pharmaceutically acceptable acid salts of glucosamine

Also Published As

Publication number Publication date
DD272034A5 (de) 1989-09-27
CS265224B2 (en) 1989-10-13
AU606038B2 (en) 1991-01-31
IN168295B (cs) 1991-03-09
GB8524807D0 (en) 1985-11-13
ZA867664B (en) 1987-05-27
WO1987002244A1 (en) 1987-04-23
JPS63501077A (ja) 1988-04-21
CS729286A2 (en) 1989-01-12
EP0239607A1 (en) 1987-10-07
AU6409486A (en) 1987-05-05

Similar Documents

Publication Publication Date Title
CA1289885C (en) Tissue growth regulation
AU584914B2 (en) Angiogenic factor and method for producing angiogenesis
DK174400B1 (da) Acylderivater af deoxyribonucleosider og farmaceutiske præparater indeholdende disse
CA1322956C (en) Process for the production of dried earthworm powder and antihyperlipemic, antidiabetic, antihypertensive and antihypotensive preparations containing dried earthworm powder as active ingredient
EP0147375A1 (en) Water-soluble aminated Beta-1,3-bound D-glucan and composition containing same
EP0296620A2 (en) Use of N-acetylneuraminic-acid salts for the preparation of a medicament for decongesting nasal mucous membranes
DE3267039D1 (en) Stable s-adenosylmethionine salts, the process for their preparation and therapeutic compositions which contain them as active principle
US4308257A (en) Accelerating cellular repair composition for the human body and method of administering same
WO1992002231A1 (en) Anti-human immunodeficiency virus agent
Whitby Enzymic formation of a new riboflavin derivative
JPH10182703A (ja) 低分子量のフカン類とその医薬組成物
EP0410002A1 (en) Anti-hiv drug
KR100239946B1 (ko) 자라와 거북의 조성물
JPH0427964B2 (cs)
Price et al. The treatment of mycosis fungoides with ointment-based mechlorethamine
Lewis The failure of purified penicillin to retard the growth of grafts of sarcoma in mice
JPH0245495A (ja) ビスマス（リン酸／硫酸）サッカリド
CA1286227C (en) Externally applicable, antiviral pharmaceutical composition accumulating in the skin and process for the preparation of same
KR100808630B1 (ko) 클로린 화합물을 포함하는 경구투여용 항종양 조성물
US4436732A (en) Medicated compound for treating diseases infected by virus of the herpes group
EP0392662B1 (en) Use of complexes of tetrachloroplatinate with a diazo dye as antitumour agents
RU2110272C1 (ru) Средство для лечения термических поражений кожи, трофических язв, пролежней и длительно незаживающих ран
OTSUKA et al. Inhibitory Effect of D-Penicillamine on Degradation of Hexosaminecontaining Substances in the Involution of Carrageenin Granuloma induced by Calcium Chelate Ethylenediaminetetraacetate
KR20040081118A (ko) 대추나무주홍하늘소 유충의 똥을 유효성분으로 하는 피부외용약
Carr et al. Effect of alginate on the absorption and excretion of 203Pb in rats fed milk and normal diets

Legal Events

Date Code Title Description
MKLA Lapsed